HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diana Bilton Selected Research

Pharmaceutical Preparations

1/2020Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis.
1/2018Use of a rare disease patient registry in long-term post-authorisation drug studies: a model for collaboration with industry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Diana Bilton Research Topics

Disease

38Cystic Fibrosis (Mucoviscidosis)
01/2022 - 03/2005
15Bronchiectasis
01/2019 - 11/2006
10Infections
01/2020 - 11/2006
4Pseudomonas Infections
11/2021 - 11/2006
2Exocrine Pancreatic Insufficiency
01/2022 - 09/2008
2Disease Progression
01/2020 - 01/2018
2Respiratory Insufficiency (Respiratory Failure)
01/2019 - 05/2015
2Persistent Infection
06/2015 - 05/2009
2Cough
03/2015 - 06/2011
2Lung Diseases (Lung Disease)
01/2014 - 02/2012
2Liver Diseases (Liver Disease)
02/2010 - 09/2008
1Meconium Ileus
01/2022
1Neoplasms (Cancer)
01/2022
1Gastroesophageal Reflux (GERD)
01/2022
1Metabolic Bone Diseases (Osteopenia)
01/2021
1Rare Diseases (Rare Disease)
01/2018
1Cross Infection (Nosocomial Infection)
01/2017
1Fatigue
05/2015
1Cardiotoxicity
10/2014
1Ototoxicity
10/2014
1Inflammation (Inflammations)
01/2014
1Asthma (Bronchial Asthma)
06/2011
1Chronic Obstructive Pulmonary Disease (COPD)
05/2011
1Osteoporosis
03/2010
1Necrosis
03/2010
1Staphylococcal Infections
02/2010
1Allergic Bronchopulmonary Aspergillosis
02/2010
1Burkholderia Infections
02/2010
1Bone Resorption
08/2006
1Emphysema
06/2002

Drug/Important Bio-Agent (IBA)

13Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 05/2009
6Mannitol (Osmitrol)FDA LinkGeneric
03/2015 - 02/2012
4ivacaftorIBA
01/2022 - 01/2018
4Tobramycin (Nebcin)FDA LinkGeneric
11/2021 - 11/2006
4SolutionsIBA
11/2021 - 11/2006
3Liposomes (Liposome)IBA
11/2021 - 09/2015
3Ciprofloxacin (Cipro)FDA LinkGeneric
01/2019 - 11/2006
3Adrenal Cortex Hormones (Corticosteroids)IBA
02/2010 - 09/2008
2SuspensionsIBA
11/2021 - 01/2020
2Amikacin (A.M.K)FDA LinkGeneric
11/2021 - 01/2020
2Pharmaceutical PreparationsIBA
01/2020 - 01/2018
2Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
01/2018 - 09/2008
2AztreonamFDA LinkGeneric
11/2017 - 03/2013
2Lysine (L-Lysine)FDA Link
11/2017 - 03/2013
2DNA (Deoxyribonucleic Acid)IBA
09/2015 - 03/2014
2PowdersIBA
03/2015 - 07/2013
2Expectorants (Mucolytics)IBA
11/2014 - 01/2014
2CytokinesIBA
03/2010 - 08/2006
1Proton Pump InhibitorsIBA
01/2022
1colistinmethanesulfonic acid (colistimethate sodium)FDA LinkGeneric
01/2021
1EnzymesIBA
01/2021
116S Ribosomal RNAIBA
01/2017
1NucleotidesIBA
01/2017
1AerosolsIBA
11/2016
1PorinsIBA
06/2015
1AntigensIBA
06/2015
1Immunodominant EpitopesIBA
06/2015
1VaccinesIBA
06/2015
1dornase alfa (Pulmozyme)FDA Link
11/2014
1MacrolidesIBA
10/2014
1Colistin (Coly-Mycin)FDA Link
04/2014
1amelubantIBA
03/2014
1Leukotriene B4IBA
03/2014
1Proteins (Proteins, Gene)FDA Link
01/2014
1Azithromycin (Zithromax)FDA LinkGeneric
10/2013
12-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA
03/2013
1Oral ContraceptivesIBA
01/2013
1Glucose (Dextrose)FDA LinkGeneric
07/2011
1SmokeIBA
05/2011
1LigandsIBA
03/2010
1collagen type I trimeric cross-linked peptideIBA
03/2010
1Collagen Type I (Type I Collagen)IBA
03/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2010
1OsteocalcinIBA
03/2010
1Interleukin-6 (Interleukin 6)IBA
03/2010
1OsteoprotegerinIBA
03/2010
1dimemorfan (AT 17)IBA
11/2006
1Leukocyte Elastase (Neutrophil Elastase)IBA
02/2006
1Peptide Hydrolases (Proteases)FDA Link
02/2006
1PolymersIBA
06/2002

Therapy/Procedure

11Therapeutics
01/2019 - 02/2006
3Noninvasive Ventilation
01/2019 - 05/2015
1Transplantation
01/2022
1Patient Admission (Patient Admissions)
05/2015
1Dry Powder Inhalers
01/2014
1Nebulizers and Vaporizers (Inhaler)
03/2013
1Physical Therapy Modalities (Physical Therapy Technique)
06/2012
1Aftercare (After-Treatment)
03/2010
1Organ Transplantation
02/2010
1Terminal Care (Care, Terminal)
12/2005
1Kidney Transplantation
03/2005